hesperetin has been researched along with pyruvaldehyde in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Li, D; Mitsuhashi, S; Ubukata, M | 1 |
| Anwar, A; Fowler, M; Jenkins, G; Kandala, NB; Messenger, D; Qureshi, S; Rabbani, N; Shafie, A; Thornalley, PJ; Waldron, M; Weickert, MO; Xue, M | 1 |
| Kaufman, RJ; Li, H; Monks, TJ; O'Meara, M; Seyoum, B; Wang, JM; Yi, Z; Zhang, K; Zhang, X | 1 |
| Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
| Bednarska, K; Fecka, I | 1 |
| Rabbani, N; Thornalley, PJ | 1 |
| Gong, D; Hu, X; Liu, K; Peng, X; Zhang, G | 1 |
1 review(s) available for hesperetin and pyruvaldehyde
| Article | Year |
|---|---|
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol | 2022 |
2 trial(s) available for hesperetin and pyruvaldehyde
| Article | Year |
|---|---|
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Cell Line; Cross-Over Studies; Female; Glutathione; Glutathione Disulfide; Hep G2 Cells; Hesperidin; Humans; Lactoylglutathione Lyase; Male; Middle Aged; Models, Biological; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Stilbenes; Young Adult | 2016 |
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
4 other study(ies) available for hesperetin and pyruvaldehyde
| Article | Year |
|---|---|
Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation.
Topics: Glucose; Glucosides; Glycation End Products, Advanced; Hesperidin; High-Throughput Screening Assays; Hypoglycemic Agents; Maillard Reaction; Molecular Structure; Pyruvaldehyde; Ribonuclease, Pancreatic; Serum Albumin, Bovine; Stereoisomerism; Structure-Activity Relationship | 2012 |
Ameliorating Methylglyoxal-Induced Progenitor Cell Dysfunction for Tissue Repair in Diabetes.
Topics: Animals; Bone Marrow Cells; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Type 2; Disease Models, Animal; Endoribonucleases; Gene Knock-In Techniques; Gene Transfer Techniques; Hesperidin; Lactoylglutathione Lyase; Mice; Neovascularization, Physiologic; Protein Serine-Threonine Kinases; Pyruvaldehyde; Resveratrol; Skin; Stem Cells; Wound Healing; Wounds and Injuries | 2019 |
Potential of Vasoprotectives to Inhibit Non-Enzymatic Protein Glycation, and Reactive Carbonyl and Oxygen Species Uptake.
Topics: Animals; Antioxidants; Chromatography, High Pressure Liquid; Glycation End Products, Advanced; Hesperidin; Humans; Hydrogen-Ion Concentration; Pyruvaldehyde; Spectrometry, Mass, Electrospray Ionization | 2021 |
Exploring inhibitory effect and mechanism of hesperetin-Cu (II) complex against protein glycation.
Topics: Glycation End Products, Advanced; Maillard Reaction; Pyruvaldehyde; Serum Albumin, Bovine | 2023 |